![John Cantello](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Cantello
No open positions remaining
Health Technology
Profile
John L.
Cantello currently works at Genenta Science SpA, as Independent Director from 2024.
Dr. Cantello also formerly worked at AstraZeneca PLC, as VP & Head-BD, Respiratory & Immune Diseases and GSK Plc, as VP & Head-Business Development, Oncology Therapy.
Former positions of John Cantello
| Companies | Position | End |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
| GENENTA SCIENCE S.P.A. | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Genenta Science SpA
 Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
- Stock Market
- Insiders
- John Cantello
